It is clear that these aging-associated degenerative diseases cannot only be explained by our finding of dysregulation of the Bmi-1/p16Ink4a pathway because the loss of p16Ink4a only partially rescued some of the anomalies in Bmi-1-KO SMGs. The gene discussed is BMI1; the disease is neurodegenerative disease.